$44.25
0.140.32%
At close: Jun 12, 5:00 PM EST
$44.30
0.050.11%
After Hours: Jun 12, 6:48 PM EST
Sanofi SA Analyst Ratings
SNYNASDAQ
Sanofi Analyst Ratings and Price Targets | NASDAQ:SNY | Benzinga
Sanofi SA has a consensus price target of $61 based on the ratings of 9 analysts. The high is $65 issued by Goldman Sachs on March 21, 2025. The low is $58 issued by Morgan Stanley on September 8, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Goldman Sachs, and Argus Research on September 8, 2025, March 21, 2025, and July 26, 2024, respectively. With an average price target of $61 between Morgan Stanley, Goldman Sachs, and Argus Research, there's an implied 37.70% upside for Sanofi SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Goldman Sachs
Argus Research
1calculated from analyst ratings
Analyst Ratings for Sanofi
Loading calendar...
FAQ
What is the target price for Sanofi (SNY) stock?
The latest price target for Sanofi (NASDAQ:SNY) was reported by UBS on January 16, 2026. The analyst firm set a price target for $0.00 expecting SNY to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sanofi (SNY)?
The latest analyst rating for Sanofi (NASDAQ:SNY) was provided by UBS, and Sanofi downgraded their neutral rating.
When was the last upgrade for Sanofi (SNY)?
The last upgrade for Sanofi SA happened on September 8, 2025 when Morgan Stanley raised their price target to $58. Morgan Stanley previously had an equal-weight for Sanofi SA.
When was the last downgrade for Sanofi (SNY)?
The last downgrade for Sanofi SA happened on January 16, 2026 when UBS changed their price target from N/A to N/A for Sanofi SA.
When is the next analyst rating going to be posted or updated for Sanofi (SNY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanofi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanofi was filed on January 16, 2026 so you should expect the next rating to be made available sometime around January 16, 2027.
Is the Analyst Rating Sanofi (SNY) correct?
While ratings are subjective and will change, the latest Sanofi (SNY) rating was a downgraded with a price target of $0.00 to $0.00. The current price Sanofi (SNY) is trading at is $44.30, which is out of the analyst’s predicted range.
